ArticlePloS one2011

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.

Jaroslav Jelinek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.